BlackRock Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
JHIU
BIT
BlackRock Group's BSX Position: Q4 2016 in Review
BlackRock Group reduced its Boston Scientific (BSX) stake by 1.8% in Q4 2016, selling an estimated $5.54M and leaving 13,644,787 shares worth $295M. The position accounts for 0.14% of the portfolio, ranked #171.
BlackRock Group first reported a position in BSX in Q2 2013 and has held it in 15 quarters since. The position peaked at $350M in Q2 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.
- BlackRock Group held 13,644,787 shares of Boston Scientific worth $295M as of Q4 2016.
- BlackRock Group sold 253,900 Boston Scientific shares in Q4 2016, an estimated $5.54M.
- Boston Scientific made up 0.14% of BlackRock Group's portfolio in Q4 2016, its #171 holding.
- BlackRock Group first reported a position in Boston Scientific in Q2 2013 and has held it in 15 quarters since.
- BlackRock Group's Boston Scientific position peaked at $350M in Q2 2016.
- 556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.